TPMT and acute lymphoblastic leukemia: Karas-Kuzelicki et al. reported increased myelotoxicity in children with ALL who were heterozygous for at least one low-activity TPMT allele and for C677T and/or A1298C polymorphisms in the MTHFR gene [7].